FDA Issues Warning Over Misuse of Ketamine Therapy

Unsupervised treatment — fueled by telemedicine prescriptions — for various psychiatric problems poses a number of health risks, the agency said.

https://www.nytimes.com/2023/10/11/health/fda-ketamine-warning.html

Source: NYT Health - October 11, 2023 Category: Consumer Health News Authors: Andrew Jacobs Tags: Ketamine (Drug) Alternative and Complementary Medicine Telemedicine Mental Health and Disorders Regulation and Deregulation of Industry Food and Drug Administration your-feed-healthcare Post-Traumatic Stress Disorder Drugs (Pharmaceuticals Source Type: news